Cancer Drug Nilotinib Shows Promise for Parkinson ' s Patients
MONDAY, Dec. 16, 2019 -- A drug used to fight chronic myeloid leukemia might also relieve symptoms of Parkinson ' s disease, a new study finds.
In a phase 2 clinical trial, researchers found that the drug nilotinib (brand name: Tasigna) increased...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Clinical Trials | General Medicine | Leukemia | Nilotinib | Parkinson's Disease | Study | Tasigna